Availa Bio is now the largest shareholder so I would look to that business as the primary focus here. The logistics software is still part of the company and there are 2 subsidiaries focused primarily on that but as of now, any logistical advantage would likely be used by the company and partner companies. A spin-off has been proposed in the past. I would not be surprised to see Zimbler give up shares to spin out and start a logistics company.
SkinScience is the active subsidiary of Availa but the intentions are laid out on the website.
Availa Bio, Inc.’s proprietary process uses proven technology that creates true oil-based products soluble in liquids. Since we use pressure, not additives, like chemicals, it can deliver a safe, efficient, and scalable method to make true water-soluble Hemp/Cannabinoid beverages with no toxicity. Additionally, since the product is emulsified, it dramatically increases the absorption rate into the human body. The markedly increased absorption rate makes it significantly more bioavailable, giving it a greater medicinal effect and significantly longer stability. As a further added benefit from achieving emulsification, the size of the droplets is small enough, which eliminates nearly all discoloration. Achieving high absorption rates and bioavailability allows manufacturers the ability to significantly reduce their raw material costs.
Target Markets
Hemp/Cannabinoid oil manufacturers
Hemp/Cannabinoid infused product
Select manufacturers of: Beverage/Food
Topical pain creams
Cosmetics Industry
Edibles and tinctures
Pharmaceuticals
There is a pretty direct link here to the CBD/THC supplier One World Pharma which is currently constructing a GMP lab and processing facility in Columbia that will be able to provide base ingredients for everything that Availa is looking to target. There are a couple of investors substantial enough to be listed as shareholders in both companies but the primary ones are Carlos Defex and Veronica Defex of Solid Bridge Investments. They sold the 30 acres of grow assets to OWP and then came here to set up distribution channels in the EU. According to CNGT filing, there are 2 customers ready to go in the EU already and OWP is expecting full GMP for the EU upon the completion of their facility.
Interestingly, OWP had postponed the investment into the construction of this GMP processing facility but the initiation came right after the reorganization with Availa. They also said they were in talks with a company on infusing beverages with THC/CBD using a new emulsification process. That was in their investor presentation.
It has taken a while but it looks like it's coming together. Like I keep stressing, you do not see a fortune 500 executive come into an OTC for nothing. There is meat here.
CNGT!!
